Increased Gastrointestinal Permeability and Gut Inflammation in Children with Functional Abdominal Pain and Irritable Bowel Syndrome

被引:127
作者
Shulman, Robert J. [1 ,3 ,4 ,6 ]
Eakin, Michelle N. [5 ]
Czyzewski, Danita I. [1 ,2 ,3 ,4 ]
Jarrett, Monica [7 ]
Ou, Ching-Nan [1 ,3 ,4 ]
机构
[1] Dept Pediat, Houston, TX USA
[2] Menninger Dept Psychiat & Behav Sci, Houston, TX USA
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] Texas Childrens Hosp, Houston, TX 77030 USA
[5] A duPont Hosp Children, Wilmington, DE USA
[6] Childrens Nutr Res Ctr, Wilmington, DE USA
[7] Univ Washington, Dept Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA
关键词
D O I
10.1016/j.jpeds.2008.04.062
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives To determine gastrointestinal (GI) permeability and fecal calprotectin concentration in children 7 to 10 years o age with functional abdominal pain and irritable bowel syndrome (FAP/IBS) versus control subjects and ascertain potentia relationships with pain symptoms and stooling. Study design GI permeability and fecal calprotectin concentration were measured. Children kept a 2-week diary of pair episodes mid stooling pattern. Results Proximal GI permeability was greater in the FAP/IBS group (n = 93) compared with control subjects (n = 52) (0.59 +/- 0.50 vs 0.36 +/- 0.26, respectively; mean +/- SD; P < .001) as was colonic permeability (1.01 +/- 0.67 vs.0.81 +/- 0.43, respectively P < .05). Gastric and small intestinal permeability were similar. Fecal calprotectin concentration was greater in children with FAP/IBS compared with control children (65.5 +/- 75.4 mu g/g stool vs 43.2 +/- 39.4, respectively; P < .01). Fecal protection concentration correlated with pain interference with activities (P = .01. r(2) = 0.36). There was no correlation between G permeability and pain related symptoms. Neither permeability nor fecal calprotectin correlated with stool form. Conclusions Children with FAP/IBS have evidence of increased GI permeability and low-grade GI inflammation, with the latter relating to die degree to which pain interferes with acthities. (J Pediatr 2008.153:646-50)
引用
收藏
页码:646 / 650
页数:5
相关论文
共 35 条
[21]   Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children [J].
Olafsdottir, E ;
Aksnes, L ;
Fluge, G ;
Berstad, A .
ACTA PAEDIATRICA, 2002, 91 (01) :45-50
[22]   Childhood functional gastrointestinal disorders: Child/adolescent [J].
Rasquin, Andree ;
Di Lorenzo, Carlo ;
Forbes, David ;
Guiraldes, Ernesto ;
Hyams, Jeffrey S. ;
Staiano, Annamaria ;
Walker, Lynn S. .
GASTROENTEROLOGY, 2006, 130 (05) :1527-1537
[23]   Childhood functional gastrointestinal disorders [J].
Rasquin-Weber, A ;
Hyman, PE ;
Cucchiara, S ;
Fleisher, DR ;
Hyams, JS ;
Milla, PJ ;
Staiano, A .
GUT, 1999, 45 :60-68
[24]   ASSESSMENT OF THE NEUTROPHIL DOMINATING PROTEIN CALPROTECTIN IN FECES - A METHODOLOGIC STUDY [J].
ROSETH, AG ;
FAGERHOL, MK ;
AADLAND, E ;
SCHJONSBY, H .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 (09) :793-798
[25]   THE TREATMENT OF RECURRENT ABDOMINAL-PAIN IN CHILDREN - A CONTROLLED COMPARISON OF COGNITIVE-BEHAVIORAL FAMILY INTERVENTION AND STANDARD PEDIATRIC CARE [J].
SANDERS, MR ;
SHEPHERD, RW ;
CLEGHORN, G ;
WOOLFORD, H .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1994, 62 (02) :306-314
[26]   Early feeding, antenatal glucocorticoids, and human milk decrease intestinal permeability in preterm infants [J].
Shulman, RJ ;
Schanler, RJ ;
Lau, C ;
Heitkemper, M ;
Ou, CN ;
Smith, EO .
PEDIATRIC RESEARCH, 1998, 44 (04) :519-523
[27]   Characteristics of pain and stooling in children with recurrent abdominal pain [J].
Shulman, Robert J. ;
Eakin, Michelle N. ;
Jarrett, Monica ;
Czyzewski, Danita I. ;
Zeltzer, Lonnie K. .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 44 (02) :203-208
[28]   Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome [J].
Spiller, RC ;
Jenkins, D ;
Thornley, JP ;
Hebden, JM ;
Wright, T ;
Skinner, M ;
Neal, KR .
GUT, 2000, 47 (06) :804-811
[29]  
Thompson WO, 2000, ROME II THE FUNCTION, P670
[30]   Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease [J].
Tibble, JA ;
Sigthorsson, G ;
Foster, R ;
Forgacs, I ;
Bjarnason, I .
GASTROENTEROLOGY, 2002, 123 (02) :450-460